Psoriasis is a medical condition in which red scales or patches are visible on the body especially near areas such as, elbow, knees and scalp. The condition occurs due to an overactive immune system. Some of the common symptoms include flaking, inflammation of the skin. Common treatments for psoriasis include, steroid creams, occlusion, light therapy and oral medications, such as biologics. It appears in most of the cases in the age 16-22 years.
MARKET DYNAMICS
The psoriasis drugs market is anticipated to grow in the forecast period owing to increasing healthcare expenditure and growing use of combination therapies. The market is likely to experience the growth due to opportunities in research and developments in the pipeline drugs for psoriasis.
MARKET SCOPE
The "Global Psoriasis Drugs Market Analysis to 2028" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of psoriasis drugs market with detailed market segmentation by therapeutic class, treatment and geography. The global psoriasis drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading psoriasis drugs market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global psoriasis drugs market is segmented on the basis of therapeutic class and treatment. Based on therapeutic class, the market is classified as vitamin-D analogues, interleukin inhibitors, tumor necrosis factor inhibitors, and other therapeutic class. Based on treatment, the psoriasis drugs market is divided as topicals, systemic and biologics.
(image)
REGIONAL FRAMEWORKThe report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global psoriasis drugs market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The psoriasis drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting psoriasis drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the psoriasis drugs market in these regions.
(image)
MARKET PLAYERSThe reports cover key developments in the psoriasis drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from psoriasis drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for psoriasis drugs market in the global market. Below mentioned is the list of few companies engaged in the psoriasis drugs market.
The report also includes the profiles of key psoriasis drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
-AbbVie Inc.
-Amgen Inc.
-AstraZeneca
-CELGENE CORPORATION
-Eli Lilly and Company
-Johnson & Johnson Services, Inc.
-Merck & Co., Inc.
-Novartis Pharmaceuticals Corporation
-Pfzer Inc.
-UCB S.A.
(image)